Skip to main content

Table 5 BCG induced cytokine production by PBMC

From: Thalidomide Treatment Reduces Tumor Necrosis Factor α Production and Enhances Weight Gain in Patients with Pulmonary Tuberculosis

 

Thalidomide treatment (n = 18)a

Placebo treatment (n = 8)a

Cytokine

Pre

Mid

Post

Pre

Mid

Post

TNFα

1871 ± 601

1274 ± 565

2504 ± 793

1875 ± 797

2283 ± 775

1815 ± 790

IFNγ

218 ± 122

549 ± 330

218 ± 58

197 ± 69

236 ± 79

231 ± 55

  1. TNFα and IFNγ levels were assayed by ELISA (as described in Materials and Methods) in the supernatants of PBMCs obtained from patients treated with either thalidomide or placebo. Results are expressed as pg/ml. aThe means for the number of patients shown in the parentheses ± SEM are given.